Nothing Special   »   [go: up one dir, main page]

Hintersteiner et al., 2005 - Google Patents

In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe

Hintersteiner et al., 2005

View PDF
Document ID
17024960896796942934
Author
Hintersteiner M
Enz A
Frey P
Jaton A
Kinzy W
Kneuer R
Neumann U
Rudin M
Staufenbiel M
Stoeckli M
Wiederhold K
Gremlich H
Publication year
Publication venue
Nature biotechnology

External Links

Snippet

As Alzheimer's disease pathogenesis is associated with the formation of insoluble aggregates of amyloid β-peptide, approaches allowing the direct, noninvasive visualization of plaque growth in vivo would be beneficial for biomedical research. Here we describe the …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group

Similar Documents

Publication Publication Date Title
Hintersteiner et al. In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe
Styren et al. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology
Watanabe et al. Molecular imaging of β-amyloid plaques with near-infrared boron dipyrromethane (BODIPY)-based fluorescent probes
Xu et al. Advances in development of fluorescent probes for detecting amyloid-β aggregates
Fu et al. Amyloid-β deposits target efficient near-infrared fluorescent probes: synthesis, in vitro evaluation, and in vivo imaging
Higuchi et al. 19F and 1H MRI detection of amyloid β plaques in vivo
Zhang et al. Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease
Yang et al. Turn-on chemiluminescence probes and dual-amplification of signal for detection of amyloid beta species in vivo
Crystal et al. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114
US7700616B2 (en) Compounds and amyloid probes thereof for therapeutic and imaging uses
Arora et al. Molecular tools to detect alloforms of Aβ and Tau: Implications for multiplexing and multimodal diagnosis of Alzheimer’s disease
Watanabe et al. In vivo fluorescence imaging of β-amyloid plaques with push–pull dimethylaminothiophene derivatives
Okamura et al. In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265
Ni et al. In-vitro and in-vivo characterization of CRANAD-2 for multi-spectral optoacoustic tomography and fluorescence imaging of amyloid-beta deposits in Alzheimer mice
Tan et al. Dual-functional red-emitting fluorescent probes for imaging beta-amyloid plaques and viscosity
Kolb et al. Tau positron emission tomography imaging
Fueyo-González et al. Environment-sensitive probes for illuminating amyloid aggregation in vitro and in zebrafish
Tu et al. Compounds for imaging amyloid-β deposits in an Alzheimer’s brain: a patent review
Chen et al. Evaluation of N, O-Benzamide difluoroboron derivatives as near-infrared fluorescent probes to detect β-amyloid and tau tangles
Liu et al. Rational design of quinoxalinone-based red-emitting probes for high-affinity and long-term visualizing amyloid-β in vivo
Tu et al. A rational design to improve selective imaging of tau aggregates by constructing side substitution on N, N-dimethylaniline/quinoxaline D-π-A fluorescent probe
Li et al. Synthesis and evaluation of curcumin-based near-infrared fluorescent probes for detection of amyloid β peptide in Alzheimer mouse models
Skoch et al. Development of an optical approach for noninvasive imaging of Alzheimer’s disease pathology
Zhang et al. In vivo three-dimensional brain imaging with chemiluminescence probes in Alzheimer’s disease models
Yanagisawa et al. Fluorine‐19 magnetic resonance imaging probe for the detection of tau pathology in female rTg4510 mice